SEC Form 4 · accession 0000899243-18-005139
AMEDISYS INC · AMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Paul North
Officer — Chief Information Officer
Period of report
Jan 20, 2018
Accepted (ET)
Feb 22, 2018 · 6:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 20, 2018 | F | 446 | $55.59 | D | 13,875 | D | |
| Common Stock | Feb 20, 2018 | M | 1,875 | $0.00 | A | 15,750 | D | |
| Common Stock | Feb 20, 2018 | M | 7,767 | $0.00 | A | 23,517 | D | |
| Common Stock | Feb 20, 2018 | F | 786 | $56.87 | D | 22,731 | D | |
| Common StockF2 | holding | — | — | — | 275 | I | Through 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3 | — | Feb 20, 2018 | M | 1,875 | D | — | — | Common Stock | 1,875 | 1,875 | D |
| Restricted Stock UnitsF4 | — | Feb 20, 2018 | M | 7,767 | D | — | — | Common Stock | 7,767 | 0 | D |
| Stock Option (Right to Buy)F5 | $32.56 | Feb 20, 2018 | A | 5,625 | A | — | Jun 2, 2025 | Common Stock | 5,625 | 5,625 | D |
Explanation of responses
- F1Includes 477 shares held in an employee stock purchase plan account.
- F2The information in this report is based on a plan statement dated as of December 31, 2017.
- F3The Restricted Stock Units ("RSUs") are subject to performance-based vesting and will vest (i) on the certification by the Compensation Committee of the Issuer's Board of Directors of the achievement of identified performance goals for fiscal years 2016 through 2018, respectively, and (ii) additional time-based vesting conditions (2016 Tranche: one-third on each of June 4, 2017, 2018 and 2019; 2017 Tranche: one-third on each of June 4, 2018, 2019 and 2020; and 2018 Tranche: one-third on each of June 4, 2019, 2020 and 2021), assuming the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs. The performance criteria for fiscal year 2017 were met.
- F4The RSUs are subject to performance-based vesting and will vest (i) on the certification by the Compensation Committee of the Issuer's Board of Directors of the achievement of identified performance goals for fiscal year 2017, and (ii) additional time-based vesting conditions and will vest in equal, 25% installments on each of January 20, 2018, January 20, 2019, January 20, 2020 and January 20, 2021, assuming the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs. The performance criteria for fiscal year 2017 were met.
- F5The performance-based vesting conditions of certain Stock Options reported on a Form 3 filed on November 14, 2016 were satisfied based on the certification by the Compensation Committee of the Issuer's Board of Directors of the achievement of identified performance goals for fiscal year 2017. The Stock Options are subject to additional time-based vesting conditions (one-third on each of June 2, 2018, June 2, 2019 and June 2, 2020), assuming the Reporting Person remains continuously employed by the Issuer on such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the Stock Options.